IFNWP2

Across TCGA pan-cancer cohorts, IFNWP2 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated IFNWP2 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher IFNWP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IFNWP2 expression acts as an unfavorable survival marker, although some lineages such as THCA and KIRC show a favorable association.

LUAD, ACC, and LUSC are the cancer types where IFNWP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.256	0.591	<.001	149	view →
ACC	OS	Tertile	All	0.279	0.816	<.001	117	view →
LUSC	DFS	Quartile	III,IV	0.275	0.853	<.001	101	view →
UCEC	OS	Tertile	All	0.557	0.729	<.001	84	view →
SKCM	OS	Tertile	IV	0.243	0.666	.003	39	view →
OV	OS	Tertile	IV	0.241	0.440	.007	36	view →
PAAD	OS	Quartile	All	0.437	0.719	.003	32	view →
THCA	DFS	Tertile	IV	1.000	0.532	.022	24	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
LAML	DFS	Tertile	All	0.181	0.588	.019	18	view →
LIHC	OS	Tertile	III,IV	0.079	0.737	.004	18	view →
GBM	OS	Tertile	All	0.304	0.452	.002	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

IFNWP2–LUAD (OS)

Open the LUAD breakdown →